Dr. Solà-Morales Serra has participated in the formulation of a new study called, Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions.
The study wants to highlight the key challenges with the current approaches to assessing the clinical, economic and health system value of antibiotics. The study faces the actual approaches, and proposes additional elements of value that address these challenges from all relevant perspectives. To conclude the analysis, the paper suggests the next steps needed to refine and implement the additional concepts proposed.
This paper was developed by a project team, which included partners from the pharmaceutical industry.
The brienfing is available in this web address.